AXL inhibition improves BRAF-targeted treatment in melanoma

Bibliographic Details
Title: AXL inhibition improves BRAF-targeted treatment in melanoma
Authors: Marta Nyakas, Karianne Giller Fleten, Mads Haugland Haugen, Nikolai Engedal, Christina Sveen, Inger Nina Farstad, Vivi Ann Flørenes, Lina Prasmickaite, Gunhild Mari Mælandsmo, Kotryna Seip
Source: Scientific Reports, Vol 12, Iss 1, Pp 1-16 (2022)
Publisher Information: Nature Portfolio, 2022.
Publication Year: 2022
Collection: LCC:Medicine
LCC:Science
Subject Terms: Medicine, Science
More Details: Abstract More than half of metastatic melanoma patients receiving standard therapy fail to achieve a long-term survival due to primary and/or acquired resistance. Tumor cell ability to switch from epithelial to a more aggressive mesenchymal phenotype, attributed with AXLhigh molecular profile in melanoma, has been recently linked to such event, limiting treatment efficacy. In the current study, we investigated the therapeutic potential of the AXL inhibitor (AXLi) BGB324 alone or in combination with the clinically relevant BRAF inhibitor (BRAFi) vemurafenib. Firstly, AXL was shown to be expressed in majority of melanoma lymph node metastases. When treated ex vivo, the largest reduction in cell viability was observed when the two drugs were combined. In addition, a therapeutic benefit of adding AXLi to the BRAF-targeted therapy was observed in pre-clinical AXLhigh melanoma models in vitro and in vivo. When searching for mechanistic insights, AXLi was found to potentiate BRAFi-induced apoptosis, stimulate ferroptosis and inhibit autophagy. Altogether, our findings propose AXLi as a promising treatment in combination with standard therapy to improve therapeutic outcome in metastatic melanoma.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-2322
Relation: https://doaj.org/toc/2045-2322
DOI: 10.1038/s41598-022-09078-z
Access URL: https://doaj.org/article/9ed4fda92ae4471a8ea70e8ac8bab465
Accession Number: edsdoj.9ed4fda92ae4471a8ea70e8ac8bab465
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20452322
DOI:10.1038/s41598-022-09078-z
Published in:Scientific Reports
Language:English